Australien. Out-of-pocket costs for people receiving Opioid Agonist Treatment (OAT) equates to one-eight of their income new study shows
Australien. Out-of-pocket costs for people receiving Opioid Agonist Treatment (OAT) equates to one-eight of their income new study shows
Out-of-pocket costs associated with Opioid Agonist Treatment (OAT) equate to one-eighth of participants income, representing a substantial financial burden says new study.
Researchers at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney surveyed 402 people receiving OAT (including methadone and buprenorphine) in New South Wales, Victoria, and Tasmania and found that the vast majority paid some out-of- pocket costs.
Professor Michael Farrell, Director of NDARC said; “The mean monthly total out-of-pocket costs reported by OAT participants were AU$185, accounting for approximately one-eighth of their monthly income.” (National Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Australien, 02.11.2021)
https://ndarc.med.unsw.edu.au/news/out-pocket-costs-people-receiving-opioid-agonist-treatment-oat-equates-one-eight-their-income